X-70035394-G-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001399.5(EDA):c.961G>T(p.Glu321*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001399.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- tooth agenesis, selective, X-linked, 1Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- X-linked hypohidrotic ectodermal dysplasiaInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EDA | ENST00000374552.9 | c.961G>T | p.Glu321* | stop_gained | Exon 8 of 8 | 1 | NM_001399.5 | ENSP00000363680.4 | ||
| EDA | ENST00000374553.6 | c.955G>T | p.Glu319* | stop_gained | Exon 8 of 8 | 1 | ENSP00000363681.2 | |||
| EDA | ENST00000524573.5 | c.946G>T | p.Glu316* | stop_gained | Exon 8 of 8 | 1 | ENSP00000432585.1 | |||
| EDA | ENST00000616899.1 | c.565G>T | p.Glu189* | stop_gained | Exon 7 of 7 | 5 | ENSP00000481963.1 |
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 21
ClinVar
Submissions by phenotype
Hypohidrotic X-linked ectodermal dysplasia Pathogenic:1
The Glu321X variant in EDA has been reported in one individual with X-linked hyp ohidrotic ectodermal dysplasia and was absent from 60 control X chromosomes (Mon real 1998). In addition, this variant leads to a premature stop codon at positi on 321, which is predicted to result in a truncated or absent protein. Heterozyg ous and hemizygous loss of function of the EDA gene is an established disease me chanism in XLHED. Therefore, this variant is highly likely to be pathogenic. -
EDA-related disorder Pathogenic:1
The EDA c.961G>T variant is predicted to result in premature protein termination (p.Glu321*). This variant was reported in an individual with X-linked hypohidrotic ectodermal dysplasia (reported as G1202T/E321Ter in Monreal et al. 1998. PubMed ID: 9683615). This variant has not been reported in a large population database, indicating this variant is rare. Nonsense variants in EDA are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation, as the last 71 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26345974, 12949972, 9683615) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at